The company's financial leverage remains a primary concern, with the debt-to-equity ratio climbing to 1.16 and a deepening retained earnings deficit of $851.1 million as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|
| Total Current Assets | 1.08B | 1.15B | 1.12B | 895M | 921M | 946.1M | 801.5M | 525.5M | 588.32M | 563.23M | 361.95M | 310.96M | 268.65M | 82.51M |
| Cash & Short-Term Investments | 182.3M | 239.9M | 269.5M | 195.9M | 282.9M | 389.9M | 317.9M | 92.7M | 184.31M | 174.91M | 69.7M | 57.93M | 74.92M | 13.03M |
| Cash Only | 182.3M | 239.9M | 269.5M | 195.9M | 282.9M | 389.9M | 317.9M | 92.7M | 184.31M | 174.91M | 69.7M | 57.93M | 74.92M | 13.03M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 603.4M | 602.2M | 579.1M | 496.4M | 456.3M | 430.2M | 382.2M | 326.9M | 316.14M | 295.62M | 227.64M | 186.19M | 153.63M | 62.49M |
| Days Sales Outstanding | 64.08 | 66.43 | 67.87 | 66.05 | 65.59 | 70.57 | 75 | 65.15 | 65.14 | 80.45 | 72.54 | 70.8 | 139.05 | 80.15 |
| Inventory | 100.5M | 96.6M | 88.4M | 75.2M | 71.4M | 61.1M | 56.4M | 46.3M | 43.36M | 44.95M | 28.78M | 25.59M | 23.69M | 4.57M |
| Days Inventory Outstanding | 13.32 | 13.86 | 13.62 | 13.1 | 13.27 | 12.86 | 13.91 | 12.01 | 11.63 | 16.18 | 12.79 | 13.96 | 34.02 | 9.82 |
| Other Current Assets | 157.5M | 170.9M | 182.4M | 96.5M | 79M | 39.3M | 27.4M | 41.8M | 28.28M | 30.9M | 24.68M | 33.83M | 18.03M | 8.95M |
| Total Non-Current Assets | 6.96B | 7.09B | 6.77B | 5.98B | 5.76B | 5.17B | 4.61B | 4.49B | 4.09B | 4.06B | 1.94B | 1.8B | 1.59B | 392.19M |
| Property, Plant & Equipment | 1.42B | 1.44B | 1.38B | 1.22B | 1.16B | 953.8M | 854.7M | 821M | 426.29M | 398.54M | 204.25M | 184.55M | 175.01M | 20.8M |
| Fixed Asset Turnover | 2.33x | 2.29x | 2.25x | 2.24x | 2.20x | 2.33x | 2.18x | 2.23x | 4.16x | 3.37x | 5.61x | 5.20x | 2.30x | 13.68x |
| Goodwill | 0 | 5.19B | 5.07B | 4.33B | 4.14B | 3.91B | 3.47B | 3.4B | 3.38B | 3.35B | 1.56B | 1.41B | 1.3B | 339.52M |
| Intangible Assets | 5.25B | 41M | 45.7M | 54.8M | 42.3M | 43.7M | 46.9M | 47.3M | 54.29M | 58.91M | 48.02M | 53.57M | 54.89M | 26.98M |
| Long-Term Investments | 909M | 234M | 215.4M | 184.1M | 190.3M | 88.7M | 90.3M | 93.2M | 78.48M | 74.28M | 34.98M | 34.1M | 33.44M | 0 |
| Other Non-Current Assets | 72.8M | 56.8M | 57.5M | 103.3M | 144.2M | 59.1M | 27M | 30.8M | 36.85M | 48.66M | 16.75M | 21.47M | 24.28M | 4.89M |
| Total Assets | 8.04B | 8.24B | 7.89B | 6.88B | 6.68B | 6.12B | 5.41B | 5.02B | 4.68B | 4.62B | 2.3B | 2.11B | 1.86B | 474.7M |
| Asset Turnover | 0.42x | 0.40x | 0.39x | 0.40x | 0.38x | 0.36x | 0.34x | 0.36x | 0.38x | 0.29x | 0.50x | 0.46x | 0.22x | 0.60x |
| Asset Growth % | 17.33% | 4.46% | 14.74% | 2.91% | 9.23% | 13.01% | 7.86% | 7.33% | 1.16% | 100.56% | 9.41% | 13.34% | 291.57% | - |
| Total Current Liabilities | 581.7M | 615.5M | 624.4M | 523M | 493.4M | 536.8M | 556.8M | 398.1M | 349.3M | 303M | 186.72M | 181.31M | 141.39M | 42.45M |
| Accounts Payable | 168.6M | 208.7M | 208.7M | 171.8M | 151.6M | 124.9M | 100.2M | 96.7M | 83.29M | 84.71M | 49.77M | 45.34M | 43.06M | 18.28M |
| Days Payables Outstanding | 25.7 | 29.95 | 32.16 | 29.92 | 28.17 | 26.3 | 24.71 | 25.07 | 22.33 | 30.5 | 22.12 | 24.73 | 61.84 | 39.28 |
| Short-Term Debt | 142.6M | 142M | 101.4M | 73.3M | 62.8M | 60.4M | 64.4M | 56M | 55.6M | 58.73M | 27.82M | 27.27M | 22.09M | 8.84M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 3.2M | 64.4M | 109.8M | 0 | -138.84M | -143.44M | -77.59M | -72.61M | 58.98M | 0 |
| Other Current Liabilities | 193.4M | 199.9M | 24.8M | 23.9M | 49.1M | 47.3M | 38.1M | 22.5M | 135.19M | 19.48M | 25.71M | 49.38M | 24.37M | 4.33M |
| Current Ratio | 1.86x | 1.87x | 1.79x | 1.71x | 1.87x | 1.76x | 1.44x | 1.32x | 1.68x | 1.86x | 1.94x | 1.72x | 1.90x | 1.94x |
| Quick Ratio | 1.69x | 1.71x | 1.65x | 1.57x | 1.72x | 1.65x | 1.34x | 1.20x | 1.56x | 1.71x | 1.78x | 1.57x | 1.73x | 1.84x |
| Cash Conversion Cycle | 51.7 | 50.35 | 49.33 | 49.22 | 50.69 | 57.14 | 64.2 | 52.08 | 54.43 | 66.14 | 63.21 | 60.03 | 111.23 | 50.68 |
| Total Non-Current Liabilities | 3.98B | 4.1B | 3.63B | 2.99B | 2.91B | 3.28B | 3.23B | 2.92B | 2.54B | 2.98B | 1.61B | 1.44B | 1.5B | 446.62M |
| Long-Term Debt | 2.73B | 2.71B | 3.27B | 2.7B | 2.56B | 2.88B | 2.79B | 2.52B | 2.25B | 2.13B | 1.41B | 1.22B | 1.39B | 418.56M |
| Capital Lease Obligations | 3.73B | 1.18B | 292.1M | 248.9M | 271.4M | 315.6M | 300.9M | 283.1M | 166.34M | 121.63M | 0 | 7.15M | -18.18M | 0 |
| Deferred Tax Liabilities | 307.8M | 175.7M | 39.2M | 0 | 0 | 0 | 0 | 0 | 52.28M | 28.38M | 122.35M | 63.99M | 49.17M | 16.02M |
| Other Non-Current Liabilities | 41.6M | 41.2M | 30.2M | 41.1M | 75.4M | 87M | 139.7M | 113.6M | 121.49M | 100.85M | 198.62M | 211.46M | 35.48M | 12.04M |
| Total Liabilities | 4.56B | 4.72B | 4.25B | 3.51B | 3.4B | 3.82B | 3.79B | 3.32B | 4.68B | 4.62B | 2.3B | 2.11B | 1.64B | 489.08M |
| Total Debt | 4.03B | 4.02B | 3.7B | 3.06B | 2.93B | 3.29B | 3.2B | 2.9B | 2.48B | 2.19B | 1.5B | 1.31B | 1.41B | 427.4M |
| Net Debt | 3.85B | 3.78B | 3.43B | 2.87B | 2.65B | 2.9B | 2.88B | 2.81B | 2.29B | 2.01B | 1.43B | 1.26B | 1.34B | 414.38M |
| Debt / Equity | 1.16x | 1.14x | 1.02x | 0.91x | 0.89x | 1.43x | 1.97x | 1.71x | 2.25x | 1.64x | 4.61x | 4.41x | 6.37x | - |
| Debt / EBITDA | 7.05x | 7.12x | 7.39x | 6.86x | 6.37x | 8.22x | 11.51x | 9.29x | 17.04x | 10.42x | 6.34x | 7.33x | 21.48x | 6.12x |
| Net Debt / EBITDA | 6.73x | 6.69x | 6.85x | 6.42x | 5.75x | 7.24x | 10.36x | 8.99x | 15.78x | 9.58x | 6.05x | 7.00x | 20.34x | 5.93x |
| Interest Coverage | 1.35x | 1.43x | 1.73x | 1.70x | 1.47x | 1.37x | 0.91x | 1.31x | 0.53x | 1.70x | 2.05x | 0.25x | 0.82x | 2.16x |
| Total Equity | 3.48B | 3.53B | 3.64B | 3.36B | 3.28B | 2.3B | 1.62B | 1.7B | 1.1B | 1.34B | 324.67M | 297.93M | 222.13M | -14.38M |
| Equity Growth % | -6.87% | -2.98% | 8.13% | 2.41% | 42.75% | 41.67% | -4.47% | 54.64% | -17.78% | 311.68% | 8.98% | 34.13% | 1645.22% | - |
| Book Value per Share | 27.12 | 27.72 | 28.82 | 26.76 | 35.70 | 31.75 | 33.28 | 35.20 | 22.88 | 27.28 | 6.74 | 7.95 | 4.61 | -0.30 |
| Total Shareholders' Equity | 1.69B | 1.71B | 1.79B | 1.99B | 2B | 1.09B | 550.1M | 691.8M | 404.64M | 654.73M | 9.68M | -4.03M | -264.08M | -103.62M |
| Common Stock | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | 900K | 500K | 500K | 489K | 487K | 485K | 482K | 0 | 0 |
| Retained Earnings | -851.1M | -815.2M | -737.3M | -569.2M | -557.3M | -502.7M | -431.8M | -315.7M | -247.02M | -41.32M | -311.35M | -320.8M | -322.23M | -163.34M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -10.5M | -13.8M | 4.8M | 57.5M | 76.2M | -31.5M | -61M | -50.7M | -22.45M | -19.68M | -86.39M | -70.24M | -55.7M | -17.19M |
| Minority Interest | 1.79B | 1.81B | 1.85B | 1.37B | 1.28B | 1.21B | 1.07B | 1.01B | 694.3M | 681.88M | 315M | 301.95M | 486.21M | 89.24M |
High Debt-to-Equity Burden
As reported in recent financial statements, SGRY's debt-to-equity ratio has climbed steadily from 0.91 in 2023Q4 to 1.16 by 2026Q1, indicating that the company's reliance on debt-funded acquisitions is increasingly straining its capital structure and potentially limiting its future strategic maneuverability in a volatile rate environment.
The consistent rise in the debt-to-equity ratio suggests that the company is prioritizing inorganic growth over balance sheet deleveraging. Investors should monitor whether this leverage trajectory remains sustainable, as the persistent reliance on debt to fund facility acquisitions may heighten refinancing risks if interest rates remain elevated.
Based on the company's balance sheet data, goodwill has expanded from $4.3 billion in 2023Q4 to $5.2 billion in 2026Q1, representing a significant portion of total assets and suggesting that the firm's valuation is heavily dependent on the successful integration of past and future facility acquisitions.
The concentration of goodwill within the asset base implies that the company's book value is highly sensitive to potential impairment charges if acquired facilities fail to meet performance expectations. This asset-heavy structure warrants further investigation into the underlying cash-generating capacity of these acquired units relative to their carrying values.
According to quarterly filings, SGRY's cash position has fluctuated significantly, dropping to $182.3 million in 2026Q1 from a peak of $269.5 million in 2024Q4, which may indicate a tightening liquidity buffer as the company navigates ongoing operational costs and debt service requirements in a challenging market.
While the current ratio remains above 1.8, the absolute cash levels appear modest relative to the company's scale and debt obligations. This suggests that the firm may have limited room for error should working capital requirements or unexpected operational headwinds necessitate additional liquidity in the near term.
As indicated by the company's balance sheet, the deficit in retained earnings has deepened from -$569.2 million in 2023Q4 to -$851.1 million in 2026Q1, reflecting a persistent inability to generate cumulative net profitability despite the company's aggressive expansion and revenue growth efforts over the last ten quarters.
The widening deficit in retained earnings suggests that the company's core operations are not yet producing sufficient bottom-line results to offset historical losses. This trend may indicate that the current business model requires significant structural adjustments to achieve long-term equity value creation for shareholders.
Quick answers to the most common questions about buying SGRY stock.
As of 2025, Surgery Partners, Inc. (SGRY) had total assets of $8.24B including $1.15B in current assets.
Surgery Partners, Inc. (SGRY) carries total debt of $4.02B, offset by $239.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Surgery Partners, Inc. (SGRY) has total shareholders' equity (book value) of $1.71B ($27.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Surgery Partners, Inc. (SGRY) reported a current ratio of 1.87x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.